http://venturebeat.com/2007/07/24/horizon-therapeutics-combining-generic-pain-meds-for-greater-drug-safety/ News About Tech, Money and Innovation Mon, 23 Nov 2009 03:59:39 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/07/24/horizon-therapeutics-combining-generic-pain-meds-for-greater-drug-safety/comment-page-1/#comment-689992 VentureBeat » Life sciences briefing: Friday, Dec. 21, 2007 Sat, 22 Dec 2007 01:31:35 +0000 http://venturebeat.com/2007/07/24/horizon-therapeutics-combining-generic-pain-meds-for-greater-drug-safety/#comment-689992 [...] Cogentus aims to combine existing drugs in fixed doses in order to reduce side effects. The company’s lead candidate, CGT-2168, combines the blood thinner clopidogrel with omeprazol, a treatment that reduces gastrointestinal side effects. Cogentus is one of several specialty pharmaceutical companies pursuing this strategy, which does have the potential drawback that doctors may simply prescribe the drugs separately instead of paying extra for the combined formulation. We covered Horizon Therapeutics, which is doing the same thing with pain drugs, here. [...] [...] Cogentus aims to combine existing drugs in fixed doses in order to reduce side effects. The company’s lead candidate, CGT-2168, combines the blood thinner clopidogrel with omeprazol, a treatment that reduces gastrointestinal side effects. Cogentus is one of several specialty pharmaceutical companies pursuing this strategy, which does have the potential drawback that doctors may simply prescribe the drugs separately instead of paying extra for the combined formulation. We covered Horizon Therapeutics, which is doing the same thing with pain drugs, here. [...]

]]>